19 Oct
2021

Investment in medical device IP is surging

After a tough 2020 for med-tech deal-making, diagnostic innovation buyouts are driving a resurgence in IP-rich acquisitions

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth